Navigation Links
Clinical pharmacists can reduce drug costs
Date:12/23/2008

Clinical pharmacy services can significantly reduce the cost of prescription drugs and save money elsewhere in the health care system, according to a new study by researchers at the University of Illinois at Chicago.

For every dollar spent by hospitals or health systems to provide clinical pharmacy services, $4.81 was saved through lower drug costs, reductions in adverse drug events and medication errors and other savings, says Glen Schumock, associate professor and director of UIC's Center for Pharmacoeconomic Research and senior researcher on the study.

Schumock and his colleagues evaluated 93 studies published between 2001 and 2005 to uncover the impact of clinical pharmacy services, defined as services that involve direct patient care by a clinical pharmacist. Unlike traditional pharmacy services, in which a pharmacist dispenses medications, clinical pharmacists make recommendations to physicians regarding drug therapy or sometimes even help write the prescription.

Clinical pharmacy services in the studies examined were provided in hospitals, community pharmacies, nursing homes and other facilities. Such services have been available since the late 1970s but have only recently become common, Schumock said.

"The expansion of clinical pharmacy services is one potential mechanism that could be more greatly employed to curb the problem of prescription drug spending," he said.

Prescriptions in the United States cost $287 billion in 2007, and the rising cost of drugs is often cited as a problem in the country's health care system. Health care accounted for 16 percent of the U.S. gross domestic product in 2006, costing $2.1 trillion, according to the Centers for Medicare and Medicaid Services.


'/>"/>

Contact: Sam Hostettler
samhos@uic.edu
312-355-2522
University of Illinois at Chicago
Source:Eurekalert

Page: 1

Related medicine news :

1. What is the clinical character of Fitz-Hugh-Curtis syndrome?
2. Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine Conference
3. Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
4. Pexiganan Phase 3 Clinical Trials Results Published in December Issue of CID
5. Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia
6. Molecular therapy for spinal muscular atrophy closer to clinical use
7. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
8. CMV Infection in Transplant Recipients: Clinical Cases and Expert Opinion
9. CRSTI and Medical City Hospital Dallas Currently Recruiting For a Phase 2 Clinical Trial of MYDICAR(R) for Advanced Heart Failure
10. The American Federation for Medical Research Says Daschle Must Cure Clinical Research Crisis if Change Is To Take Hold in U.S. Health Care System
11. AAOS Issues New Clinical Practice Guideline for Osteoarthritis of the Knee

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...SNewswire/ -- The American Public Health Associati...visions in the health reform bill passed last nigh...the House takes important steps toward universal c...d moving our health system from one that focuses o... people healthy," said Georges C. Benjamin, MD, FA...
(Date:11/8/2009)...es self-assurance, research finds , , SU...ave been right when she told you to sit up straigh...ake you feel more confident about your thoughts. ...ght gives a good impression to other people," Rich... professor at Ohio State University, said in a uni...
(Date:11/8/2009)...e game later, doctors say , , SUNDAY, No...k of the NFL this season, sidelining such stars as...arker. , Officials at the American Podiatric Me...c Sports Medicine are warning athletes to take car...otball and lacrosse. , "Many fall sports athlet...
(Date:11/8/2009)...ewswire/ -- Speaker Nancy Pelosi and Democratic le...passage of H.R. 3962, the Affordable Health Care f...to 215. Below are the Speaker,s opening remarks: ...a call from the President of the United States, Ba...or the American people. I thank the President for ...
(Date:11/8/2009)...d "Preventing and Healing AIDS Through Our In...at AIDS is a result of multiple, repeated and chro...em stressor agents, which can be either chemical, ... , Oakland, CA (PRWEB) No...l biologists, physicians, chemists and other scien...
Breaking Medicine News(10 mins):Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Good Posture May Inspire Confidence 2Health News:Rx for Fall Foot Injuries 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3
...ty researchers have identified the role of a key e... the way for new target therapies to reduce plaque...predict a patients susceptibility to heart disease...plaques. , Heart disease results from the format...
...s for respiratory health , , WEDNESDAY, Oc...ngs, a couple of drinks a day may help keep the do...le evidence has mounted that a daily dose of alcoh... the possible protective effect of alcohol involvi...
...ompany Becomes First to Leverage Zagat,s, Expertis...de Feedback and Rate Experiences Using Zag...W YORK, Oct. 24 WellPoint, Inc., the,nation,s lar... their physician experiences with others. A first ...
...ydrate, a novel,medical humidifier, was awarded a ... October 18, 2007. PARI Innovative Manufacturers, ...rs, developed the PARI Hydrate to,revolutionize th...The award, selected by an independent panel of jud...
...ced in healthy volunteers, according to a study by...Diego (UCSD) Center for Medical Cannabis Research ...may be more. , In the placebo controlled study of...results suggest a "therapeutic window" for cannabi...
... the,leading cause of death in the United States, ...izophrenia. The November 2007 issue of the Harvard...great for people with,schizophrenia and what can t... They are also less,likely to receive good prevent...
Other Medicine News:Health News:Role of a key enzyme in reducing heart disease identified 2Health News:Drink or Two a Day May Help Lungs 2Health News:Drink or Two a Day May Help Lungs 3Health News:Drink or Two a Day May Help Lungs 4Health News:WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 2Health News:WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 3Health News:PARI's Hydrate Wins Prestigious R&D 100 Award 2Health News:Smoked cannabis proven effective in treating neuropathic pain 2Health News:People with Schizophrenia More Likely to Die of Heart Disease, Reports the Harvard Mental Health Letter 2
(Date:11/6/2009)....C., Nov. 6 Chimerix, Inc., a biop...ntiviral therapeutics to address life-threatening ...the company,s lead antiviral compound, CMX001, to ... Health Security Initiative (GHSI). CMX001 is a b...the treatment of smallpox, as well as other seriou...
(Date:11/6/2009)...re-FirstCall/ -- Caraco Pharmaceutical Laboratorie...tromethamine ophthalmic solution, 0.5% following a...ration (FDA) for Sun Pharma,s Abbreviated New Drug...lmic solution on the first day following patent ex...cally equivalent to Acular® Ophthalmic Soluti...
(Date:11/5/2009)...swire/ -- Althea Technologies, Inc., a leading pro...r biopharmaceutical products announced the additio...pany,s platform of services, which will be oversee...tor of Formulation Development. This investment in... scientists, along with new laboratory facilities ...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services 2RiversEdge BioVentures LLC to Provide Advisory and Investment Services in Life Sciences 13993 1RiversEdge BioVentures LLC to Provide Advisory and Investment Services in Life Sciences 13993 2GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 1GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 2GENova to acquire three new drug target patents worth in excess of 241 billion in royalty fees 56862 3Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 1Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 2Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 3Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid 56858 4
...l Therapeutics (CTI),(Nasdaq and MTA: CTIC) announ...nd Drug Administration (FDA), CTI expects to begin...) and request priority review for pixantrone to tr...L) in the first quarter of 2009.,If granted priori... the end of,2009. , "This communication from t...
...t Angiolix has similar efficacy to Avastin alone a...th potentially less side-effects; study validates ...DALLAS, Jan. 26 ACCESS PHARMACEUTICALS, INC. (OTC...k on its proprietary humanized monoclonal antibody... with high affinity to the its target, lactadherin...
Other Medicine Technology:Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission 2Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission 3Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 2Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody 3
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: